Disease | adenocarcinoma |
Phenotype | C0080032|malignant pleural effusions |
Sentences | 5 |
PubMedID- 22124476 | Methods: lung adenocarcinoma patients with malignant pleural effusions having wild-type egfr and measurable target lesions were enrolled for eml4-alk analysis by reverse transcription-polymerase chain reaction and direct sequencing. |
PubMedID- 24309934 | We have recently reported that cell cultures derived from malignant pleural effusions (mpes) of patients affected by adenocarcinoma of the lung are able to efficiently form spheroids in non-adherent conditions supplemented with growth factors. |
PubMedID- 24587142 | Some studies have analyzed the egfr mutation rate in pleural effusions and the relationship between the mutation rate and patient response to gefitinib,[8]–[11] whereas a previous study investigated the egfr mutation rate in malignant pleural effusions (mpes) of lung adenocarcinoma and compared it with the mutation rate in surgically resected specimens of lung adenocarcinoma from patients without mpes. |
PubMedID- 22489699 | Using enzyme-linked immunoadsorbent assay, the concentrations of vegf and sicam-1 were measured in pleural effusions and serum from a total of 79 lung adenocarcinoma patients with malignant pleural effusions (mpe) and 24 patients with tuberculosis. |
PubMedID- 23896512 | We have previously described an efficient procedure to establish in vitro primary cell cultures from malignant pleural effusions of patients affected by adenocarcinoma of the lung [33]. |
Page: 1